These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23521430)

  • 1. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
    Reddy KK; Singh SK; Tripathi SK; Selvaraj C
    SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
    Reddy KK; Singh SK
    Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
    Patel SB; Patel BD; Pannecouque C; Bhatt HG
    Eur J Med Chem; 2016 Jul; 117():230-40. PubMed ID: 27105027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
    Vadivelan S; Deeksha TN; Arun S; Machiraju PK; Gundla R; Sinha BN; Jagarlapudi SA
    Eur J Med Chem; 2011 Mar; 46(3):851-9. PubMed ID: 21272964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.
    Saxena S; Chaudhaery SS; Varshney K; Saxena AK
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):445-62. PubMed ID: 20818581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of potential EGFR inhibitors: a combination of pharmacophore-based virtual screening, atom-based 3D-QSAR and molecular docking analysis.
    Sudha A; Srinivasan P; Rameshthangam P
    J Recept Signal Transduct Res; 2015 Apr; 35(2):137-48. PubMed ID: 25069678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Silico Screening of Ligand Based Pharmacophore, Database Mining and Molecular Docking on 2, 5-Diaminopyrimidines Azapurines as Potential Inhibitors of Glycogen Synthase Kinase-3β.
    Mishra P; Kesar S; Paliwal SK; Chauhan M; Madan K
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):150-158. PubMed ID: 29848281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening for natural product inhibitors of HIV-1 integrase.
    Ma SK; Wu KZ; Li AX
    Interdiscip Sci; 2011 Mar; 3(1):17-21. PubMed ID: 21369883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds].
    Yu SH; Tan YM; Zhao GS
    Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore Identification, Molecular Docking, Virtual Screening, and In Silico ADME Studies of Non-Nucleoside Reverse Transcriptase Inhibitors.
    Pirhadi S; Ghasemi JB
    Mol Inform; 2012 Dec; 31(11-12):856-66. PubMed ID: 27476739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
    Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
    J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
    Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
    Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
    Dayam R; Sanchez T; Neamati N
    J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.